Advanced Filters
noise
Found 1,274 clinical trials
Y Yunhao WU

Efficacy and Safety of tACS for Depression: a Multicenter RCT Study

Transcranial alternating current stimulation (tACS) is a promising non-invasive technique for major depression, because of its advantage of lower risks and expenses compared to other therapies such as deep brain stimulation, electroconvulsive therapy, and repetitive transcranial magnetic stimulation. Randomized controlled trials (RCTs) of depression treated by tACS have been conducted …

18 - 65 years of age All Phase N/A
S Susan K Conroy, MD PhD

rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression

The goal of this clinical trial is to learn if Transcranial Magnetic Stimulation (TMS) to part of the brain called the ventromedial prefrontal cortex (VMPFC) can treat a symptom called rumination in adults with major depression that has not responded to at least one medication trial. The main question it …

18 - 70 years of age All Phase N/A
D Daniel C Kopala-Sibley

Improving Sleep to Prevent Depression & Anxiety in Adolescents at High Risk

Emerging evidence has shown that sleep interventions such as Cognitive Behavioral Therapy for Insomnia (CBT-I) improve depressive and anxiety symptoms in adults, even when the intervention is brief, such as four to six sessions. The overarching aim of the proposed research is to conduct a pilot trial to evaluate whether …

12 - 18 years of age All Phase N/A
A Angelina Malenda

Healing At Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.

18 years of age Female Phase N/A
L Line Fønss

COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression

The CoMPACT trial is a randomized double-blinded sham-controlled study aimed at testing a novel accelerated and personalized transcranial Magnetic Stimulation (TMS) treatment for patients with Treatment Resistant Depression (TRD). CoMPACT consists of 25 sessions of intermittent theta-burst transcranial stimulation (iTBS) consisting of high inter-pulse frequency administered five times daily over …

18 - 95 years of age All Phase N/A

A Trial of a Positive Psychology Intervention for Older Adults (RESET) During the COVID-19 Pandemic

The heightened vulnerability to COVID-19 of African American older adults in Detroit, Michigan and other marginalized communities is linked to systemic racism experienced over the life course. Structural inequities also magnify the pandemic's impact on older adults' physical and psychosocial functioning. Many older adults in Detroit, burdened by poor health …

50 years of age All Phase N/A

A Precision Medicine Approach to Target Engagement for Emotion Regulation

The proposed study is designed to first test whether teaching people personalized or standardized emotion regulation skills leads to greater decreases in daily negative emotion intensity. Second, using data from an initial sample, the investigators will prospectively assign an independent sample of participants to receive their predicted optimal or non-optimal …

18 years of age All Phase N/A
D Dr Stavroula Rakitzi, PhD

The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.

The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.

18 - 65 years of age All Phase 1
T Todd Farchione, PhD

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.

18 - 64 years of age All Phase N/A
V Vanessa Evans

Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study

Antidepressants are widely used as first-line treatments for major depressive disorder (MDD). Clinical guidelines recommend 6-24 months of "maintenance" antidepressant treatment, after patients achieve symptom remission, to prevent relapse but many people stop antidepressants too soon relapse into another depressive episode. We will test non-medication treatments, negative ion therapy and …

19 - 65 years of age All Phase N/A

Simplify language using AI